North America active pharmaceutical ingredients (API) market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 82 tables and 75 figures, this 197-page report "North America Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire North America active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Molecule, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Other Biotech APIs
o by Category
Innovative Biologic API
Generic Biosimilar API
o by Expression
Mammalian Expression
Microbial Expression
Yeast Expression
Insect Expression
Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o by Drug Type
Branded Merchant API
Generic Merchant API
o by Drug Synthesis
Merchant Synthetic API
Merchant Biotech API
By Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32
2.2 Major Growth Drivers 36
2.3 Market Restraints and Challenges 44
2.4 Emerging Opportunities and Market Trends 47
2.5 Porter's Fiver Forces Analysis 51
3 Segmentation of North America Market by Molecule 55
3.1 Market Overview by Molecule 55
3.2 Small Molecule APIs 57
3.3 Large Molecule APIs 58
4 Segmentation of North America Market by Synthesis 59
4.1 Market Overview by Synthesis 59
4.2 Synthetic API 61
4.2.1 Branded Synthetic API 62
4.2.2 Generic Synthetic API 63
4.3 Biotech API 64
4.3.1 Biotech API by Drug Type 65
4.3.1.1 Monoclonal Antibodies 66
4.3.1.2 Recombinant Proteins 67
4.3.1.3 Vaccines 68
4.3.1.4 Other Biotech APIs 69
4.3.2 Biotech API by Category 70
4.3.2.1 Innovative Biologic API 71
4.3.2.2 Generic Biosimilar API 72
4.3.3 Biotech API by Expression Technology 73
4.3.3.1 Mammalian Expression 74
4.3.3.2 Microbial Expression 75
4.3.3.3 Yeast Expression 76
4.3.3.4 Insect Expression 77
4.3.3.5 Other Expression Technologies 78
4.4 HPAPI 79
4.4.1 Branded HPAPI 80
4.4.2 Generic HPAPI 81
5 Segmentation of North America Market by Manufacturing Process 82
5.1 Market Overview by Manufacturing Process 82
5.2 Captive Manufacturing 84
5.2.1 Branded Captive API 85
5.2.2 Generic Captive API 86
5.3 Merchant Manufacturing 87
5.3.1 Merchant Manufacturing by Drug Type 88
5.3.1.1 Branded Merchant API 89
5.3.1.2 Generic Merchant API 90
5.3.2 Merchant Manufacturing by Drug Synthesis 91
5.3.2.1 Merchant Synthetic API 92
5.3.2.2 Merchant Biotech API 93
6 Segmentation of North America Market by Therapeutic Application 94
6.1 Market Overview by Therapeutic Application 94
6.2 Infectious Diseases 96
6.3 Oncology 97
6.4 Ophthalmology 98
6.5 Cardiovascular Disorders 99
6.6 Central Nervous System 100
6.7 Pulmonary Disorders 101
6.8 Orthopedics 102
6.9 Other Applications 103
7 Segmentation of North America Market by Drug Type 104
7.1 Market Overview by Drug Type 104
7.2 Branded Prescription Drugs 106
7.3 Generic Prescription Drugs 107
7.4 OTC Drugs 108
8 North America Market 2022-2032 by Country 109
8.1 Overview of North America Market 109
8.2 U.S. 112
8.3 Canada 122
8.4 Mexico 124
9 Competitive Landscape 126
9.1 Overview of Key Vendors 126
9.2 New Product Launch, Partnership, Investment, and M&A 129
9.3 Company Profiles 130
AbbVie Inc. 130
Astrazeneca 132
Aurobindo Pharma Ltd. 137
BASF 140
Bayer AG 143
Boehringer Ingelheim 147
Catalent Inc. 152
Dr. Reddy's Laboratories 155
F. Hoffmann-La Roche 157
GlaxoSmithKline plc 160
Lonza Group 165
Lupin Limited 169
Merck & Co., Inc. 172
Mylan NV 175
Novartis International AG 178
Pfizer Inc. 181
Sanofi 186
Sun Pharmaceutical Industries Ltd. 189
Teva Pharmaceutical Industries Ltd. 192
Thermo Fisher Scientific 194
Related Reports and Products 197
Market Overview
The North America Banking as a Service (BaaS) Market is poised for significant growth from 2024 to 2034, driven by the digital transformation of financial services, the increasing demand for seamless integration of banking solutions, and the expansion of fintech partners...
Market Overview
The North America Perfume Packaging Market is set to experience robust growth from 2024 to 2034, driven by rising consumer preferences for premium fragrances, innovations in sustainable packaging, and the growing popularity of e-commerce. The market size is projected to ...
Market Overview
The North America Alternate Marine Power Market is poised for significant growth from 2024 to 2034, driven by stringent environmental regulations, rising concerns about marine pollution, and advancements in clean energy technologies. The market size is projected to expan...
Market Overview
The North America Bio Vanillin Market is projected to experience robust growth from 2024 to 2034, driven by the rising demand for natural and sustainable flavoring agents, increasing consumer preference for clean-label products, and expanding applications across various ...
Market Overview
The North America AI-Enabled Biometric Market is projected to experience substantial growth from 2024 to 2034, driven by the increasing demand for advanced, secure, and convenient identity verification solutions across various sectors. With rising adoption in areas such ...
Market Overview
The North America Commercial Vehicle Telematics Market is poised for significant growth from 2024 to 2034, driven by the rising demand for real-time fleet monitoring, enhanced vehicle safety, and regulatory mandates for fleet management. The market is expected to expand ...
Market Overview
The North America Passive Optical Network (PON) Market is set to experience substantial growth from 2024 to 2034, fueled by increasing investments in fiber-optic infrastructure and growing demand for high-speed, reliable internet connectivity. Projected to reach USD XXX....
Market Overview
The North America Safety Valves Market is anticipated to grow significantly from 2024 to 2034, driven by increasing demand across key industries such as oil & gas, energy & power, and water & wastewater treatment. Projected to reach USD XXX.XX million by 2034 from USD XX...
The Freeze-drying Pharmaceutical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Active RFID Asset Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...